Free Trial
OTCMKTS:CRNCV

Cerence (CRNCV) Stock Price, News & Analysis

Cerence logo
$9.20 -0.13 (-1.39%)
As of 07/14/2025

About Cerence Stock (OTCMKTS:CRNCV)

Key Stats

Today's Range
$8.98
$9.22
50-Day Range
$8.23
$11.00
52-Week Range
$17.25
$29.36
Volume
1.47 million shs
Average Volume
75,989 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CRNCV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cerence and its competitors with MarketBeat's FREE daily newsletter.

CRNCV Stock News Headlines

Q1 2025 Cerence Inc Earnings Call
Cerence Shares Surge After Beating 4Q Estimates
REVEALED FREE: Our top 3 stocks to own in 2025 and beyond
Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!).
CytoDyn announces FDA clearance of Phase II oncology trial
Cerence Inc. (CRNC)
See More Headlines

CRNCV Stock Analysis - Frequently Asked Questions

Cerence's stock was trading at $7.85 at the start of the year. Since then, CRNCV stock has increased by 17.2% and is now trading at $9.20.

Shares of CRNCV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Packaged Software
Sub-Industry
N/A
Current Symbol
OTCMKTS:CRNCV
CIK
N/A
Phone
N/A
Fax
N/A
Employees
1,300
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (OTCMKTS:CRNCV) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners